Healthcare Industry News: computed tomography
News Release - January 6, 2014
Stryker and NeuroLogica Partner to Provide Surgical Navigation with the BodyTom(R) Portable CT ScannerKALAMAZOO, Mich. and DANVERS, Mass., Jan. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation and NeuroLogica, a subsidiary of Samsung Electronics America Inc., announced an exclusive partnership agreement in which Stryker will promote and sell NeuroLogica's BodyTom portable full body computed tomography (CT) scanner for the specialties of neurosurgery, spine surgery, orthopaedic surgery, and trauma surgery in conjunction with the Stryker NAV3i™ Surgical Navigation Platform.
BodyTom is the world's first portable, 32-slice full body CT scanner. With an 85cm gantry and 60cm field of view, BodyTom produces high quality diagnostic images throughout the hospital, including in the operating theater where it is frequently used to provide point-of-care imaging for surgical procedures. BodyTom can be combined with surgical navigation, also known as image guided surgery, to facilitate the guidance of surgical instruments relative to a patient's anatomy, improving visualization and precision during minimally invasive surgical interventions.
The agreement will enable Stryker, an industry leader in surgical navigation, and NeuroLogica, an industry leader in point-of-care imaging, to offer a turnkey surgical solution for customers seeking to acquire these innovative technologies.
"Stryker Navigation and NeuroLogica share a commitment to offering the most advanced technologies to assist surgeons in the operating theater and deliver better outcomes for their patients," said Derek Babin, Director of Marketing for Stryker Navigation. "We are excited to partner with NeuroLogica to provide streamlined and integrated surgical solutions to our customers that will enhance the surgeon experience and simplify the purchasing process for hospitals."
"The integration of Stryker Navigation with the BodyTom CT scanner is really very exciting," said Dr. Johnny Delashaw, neurosurgeon. "The opportunity here is to be more accurate when we place our hardware in the spine and then reconfirm that our hardware is in a great position before we ever leave the room."
With Stryker's support in serving customers in neurosurgery, spine surgery, orthopaedic surgery, and trauma surgery, NeuroLogica will turn its focus on the development of new markets and clinical applications for BodyTom along with their other portable imaging solutions, CereTom® and inSPira HD®.
Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com .
NeuroLogica, a subsidiary of Samsung Electronics America Inc., brings the power of innovative imaging to patients. With a strong foundation of expertise in imaging design, development and manufacturing, NeuroLogica transforms fixed technologies into portable platforms. Today, NeuroLogica's imaging solutions are used throughout the world in intensive care units, operating rooms, emergency departments, stroke centers and other key clinical areas. For more information, please visit www.NeuroLogica.com .
About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. is a global leader in technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of televisions, smartphones, personal computers, printers, cameras, home appliances, LTE systems, medical devices, semiconductors and LED solutions. We employ 270,000 people across 79 countries with annual sales of US $187 billion. To discover more, please visit samsung.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.